SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006; 295: 2164-2167.
  • 2
    Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115: 3801-3807.
  • 3
    Hay ID. Managing patients with a preoperative diagnosis of AJCC/UICC stage I (T1N0M0) papillary thyroid carcinoma: East versus West, whose policy is best? World J Surg. 2010; 34: 1291-1293.
  • 4
    Mazzaferri EL. What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)? Oncology (Williston Park). 2009; 23: 579-588.
  • 5
    Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ. Use of radioactive iodine for thyroid cancer. JAMA. 2011; 306: 721-728.
  • 6
    Iyer NG, Morris LG, Tuttle RM, Shaha AR, Ganly I. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer. 2011; 117: 4439-4446.
  • 7
    Jonklaas J, Sarlis NJ, Litofsky D, et al. Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid. 2006; 16: 1229-1242.
  • 8
    Podnos YD, Smith DD, Wagman LD, Ellenhorn JD. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope. J Surg Oncol. 2007; 96: 3-7.
  • 9
    Ito Y, Masuoka H, Fukushima M, et al. Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg. 2010; 34: 1285-1290.
  • 10
    Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000. Trans Am Clin Climatol Assoc. 2002; 113: 241-260.
  • 11
    Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD. The risk of second primary malignancies up to 3 decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab. 2008; 93: 504-515.
  • 12
    Solans R, Bosch JA, Galofre P, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001; 42: 738-743.
  • 13
    Pace-Asciak PZ, Payne RJ, Eski SJ, Walfish P, Damani M, Freeman JL. Cost savings of patients with a MACIS score lower than 6 when radioactive iodine is not given. Arch Otolaryngol Head Neck Surg. 2007; 133: 870-873.
  • 14
    Dillman DA. Mail and Internet Surveys: The Tailored Design Method.2nd ed. New York: Wiley Interscience; 2007.
  • 15
    Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008; 15: 683-690.
  • 16
    Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009; 99: 488-490.
  • 17
    Alderman AK, Hawley ST, Waljee J, Morrow M, Katz SJ. Correlates of referral practices of general surgeons to plastic surgeons for mastectomy reconstruction. Cancer. 2007; 109: 1715-1720.
  • 18
    Goodman DC, Fisher ES, Little GA, Stukel TA, Chang CH, Schoendorf KS. The relation between the availability of neonatal intensive care and neonatal mortality. N Engl J Med. 2002; 346: 1538-1544.
  • 19
    Nallamothu BK, Rogers MA, Chernew ME, Krumholz HM, Eagle KA, Birkmeyer JD. Opening of specialty cardiac hospitals and use of coronary revascularization in Medicare beneficiaries. JAMA. 2007; 297: 962-968.
  • 20
    Wennberg JE, Barnes BA, Zubkoff M. Professional uncertainty and the problem of supplier-induced demand. Soc Sci Med. 1982; 16: 811-824.
  • 21
    Laycock WS, Siewers AE, Birkmeyer CM, Wennberg DE, Birkmeyer JD. Variation in the use of laparoscopic cholecystectomy for elderly patients with acute cholecystitis. Arch Surg. 2000; 135: 457-462.
  • 22
    Fowler FJ Jr, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA. 2000; 283: 3217-3222.
  • 23
    Jagsi R, Abrahamse P, Morrow M, Hamilton AS, Graff JJ, Katz SJ. Coordination of breast cancer care between radiation oncologists and surgeons: a survey study. Int J Radiat Oncol Biol Phys. 2012; 82: 2072-2078.
  • 24
    Shahinian VB, Kuo YF, Gilbert SM. Reimbursement policy and androgen-deprivation therapy for prostate cancer. N Engl J Med. 2010; 363: 1822-1832.
  • 25
    Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA. 2006; 296: 2815-2822.
  • 26
    Sawka AM, Rotstein L, Brierley JD, et al. Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States. Thyroid. 2007; 17: 1235-1242.
  • 27
    Clark JR, Freeman JL. Interspecialty and intraspecialty differences in the management of thyroid nodular disease and cancer. Head Neck. 2005; 27: 513-523; discussion 534-534.
  • 28
    Katz SJ, Hawley ST, Abrahamse P, et al. Does it matter where you go for breast surgery? Attending surgeon's influence on variation in receipt of mastectomy for breast cancer. Med Care. 2010; 48: 892-899.
  • 29
    Friese CR, Hawley ST, Griggs JJ, et al. Employment of nurse practitioners and physician assistants in breast cancer care. J Oncol Pract. 2010; 6: 312-316.